# Levothyroxine Sodium

NDC: 60687-464
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: American Health Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200103

FDA application: ANDA209713

## Active ingredients

- LEVOTHYROXINE SODIUM: .05 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60687-464"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60687-464
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38af4e36-b26b-485d-a6f3-7fbcf6072a0f